hydromorphone and Neoplasms

hydromorphone has been researched along with Neoplasms in 88 studies

Research

Studies (88)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (11.36)	18.7374
1990's	19 (21.59)	18.2507
2000's	29 (32.95)	29.6817
2010's	18 (20.45)	24.3611
2020's	12 (13.64)	2.80

Authors

Authors	Studies
Strassburg, CP; Tukey, RH	1
Matsuda, Y; Niki, K; Okamoto, Y; Omae, T; Takagi, T; Takemura, M; Ueda, M	1
Chen, H; Huang, C; Li, X; Lin, R; Lin, S; Liu, J; Lu, M; Luo, Y; Lv, X; Su, L; Wu, M; Zhang, Z; Zhao, S; Zhou, M; Zhu, J; Zou, H	1
Escher, M; Hentsch, L; Singovski, S; Xausa, G	1
Hui, D; Ikari, T; Imai, K; Inoue, A; Inoue, S; Matsuda, Y; Matsumoto, Y; Matsunuma, R; Miwa, S; Mori, M; Morita, T; Okamoto, S; Satomi, E; Suzuki, K; Watanabe, H; Yamaguchi, T; Yamauchi, T; Yokomichi, N	1
Dräger, DL	1
Chua, D; Jackson, LD; Selby, D; Wortzman, R	1
Bao, HG; Chen, FQ; Duan, BL; Feng, ZY; Huang, YQ; Jin, Y; Liu, YQ; Lu, Y; Ma, K; Song, T; Wang, K; Wang, L; Xie, GL; Xu, JT; Yang, XQ	1
Ishiki, H; Kiuchi, D; Sato, N; Satomi, E; Shimizu, M; Yoshida, T	1
Mercadante, S	3
Cai, Z; Chen, Y; Feng, S; Fu, J; Hong, L; Huang, C; Lai, T; Li, H; Li, X; Lin, G; Lin, R; Lin, S; Lin, Y; Lv, X; Wang, F; Wang, J; Wu, Q; Xin, M; Yang, S; Yao, Y; Zhang, G; Zhao, S; Zhu, J	1
Dong, S; Dou, Z; Knaggs, R; Li, Y; Lu, G; Ma, J; Xia, J; Yang, L; Zhao, S	1
Bayer, O; Heid, F; Laufenberg-Feldmann, R; Schuster, M	1
Aruga, E; Inoue, S; Ogata, T; Saito, Y; Tsuneto, S; Uemori, M	1
Aruga, E; Inoue, S; Saito, Y; Takahashi, H; Tsuneto, S; Uemori, M	1
Foxwell, AM; Uritsky, TJ	1
Ishizuka, H; Kiyosawa, N; Toyama, K; Watanabe, K	1
Brogan, SE; Jackman, CM; Okifuji, A; Sindt, JE; White, J; Wilding, V	1
Arthur, JA; Bruera, E; Haider, A; Hui, D; Liu, D; Park, M; Reddy, A; Smith, U; Vaughan-Adams, N; Williams, J	1
Bartholomew, P; Elwell, M; Radi, Z; Vogel, WM	1
Ahn, JB; Ahn, JS; Han, HS; Jeon, SW; Kang, JH; Kim, SR; Kim, YC; Kim, YS; Kwon, JH; Lee, KH; Lee, PB; Lee, SY; Lee, WS; Oh, HS; Oh, SY; Park, KT; Park, SW; Ryu, JS; Seol, YM; Yuh, YJ	1
Bruera, E; Didwaniya, N; Gottumukkala, RS; Reddy, A	1
Han, J; Hou, Y; Richards, HM; Shen, W; Yu, L; Yu, S	1
Bentley, JN; Patil, PG; Rosenberg, WS; Viswanathan, A	1
Csikós, Á; Kullmann, T; Pintér, T; Sipőcz, I	1
Bao, YJ; Hou, W; Hua, BJ; Knaggs, R; Kong, XY; Xia, J; Yang, L	1
Haroz, R; Moore, K	1
Bond, BS	1
Kloecker, N; Mueller, M; Nadstawek, J; Schaefer, N; Schenk, M; Schroeck, A; Standop, J; Wirz, S; Wittmann, M	1
Brunelli, C; Caraceni, A; Pigni, A	1
Lahajnar Čavlović, S; Pirc, J; Stepanović, A	1
Jager, A; Janssen, PJ; Lieverse, PJ; Oldenmenger, WH; Taal, W; van der Rijt, CC	1
Hale, ME; Kutch, M; Nalamachu, SR	1
Pillai, A; Stockler, M; Vardy, J; Warr, D	1
Sittig, HB	1
Hanks, GW; Reid, C	1
Hagen, NA; Murray, A	1
Buckley, BJ; Grosset, AB; Reder, RF; Roberts, MS; Shi, M; Swanton, RE; Woodson, ME	1
Booth, CM; Cottrell, W; Seccareccia, D; Zimmermann, C	1
Figge, V; Junker, U	1
Buckley, BJ; Kwarcinski, MA; Shi, M; Weinstein, SM	1
Clemens, KE; Klaschik, E	3
Smith, LH	1
Nadstawek, J; Wartenberg, HC; Wirz, S	1
Kumar, MG; Lin, S	1
Bruera, E; Hanson, J; Pereira, J; Tarumi, Y; Watanabe, S	1
Babul, N; Darke, AC; Dhaliwal, H; Hagen, N; Harsanyi, Z; Hays, H; Thirlwell, M	1
Babul, N; Darke, AC; Dhaliwal, HS; Hagen, N; Harsanyi, Z; Thirlwell, MP	1
Labrecque, G; Lamontagne, C; Lepage-Savary, D; Poulin, É; Provencher, L; Vanier, MC	1
Allan, S; Champion, P; Der, L; MacDonald, N	1
Bruera, E; Fainsinger, RL; Inturrisi, C; Spachynski, K; Suarez-Almazor, M; Watanabe, S	1
Bruera, E; Mount, B; Scott, J; Sloan, P; Suarez-Almazor, M	1
Belzile, M; Bruera, E; Hanson, J; Kuehn, N; Pereira, J; Watanabe, S	1
Babul, N; Hagen, NA	1
Bruera, E; Hanson, J; Lawlor, P; Turner, K	1
Belzile, M; Bruera, E; De Conno, F; Groff, L; Hanson, J; Pereira, J; Ripamonti, C	1
Belgrade, M; River, Y	1
Derby, SA	1
McCaffery, M; Pasero, C	1
Casas, JR; Cherny, N; Conno, F; Hanks, GW; Hanna, M; Kalso, E; McQuay, HJ; Mercadante, S; Meynadier, J; Poulain, P; Radbruch, L; Ripamonti, C; Sawe, J; Twycross, RG; Ventafridda, V	1
Nelson, KA; Sarhill, N; Walsh, D	1
Laval, G; Mallaret, M; Sang, B; Villard, ML	1
Kefalianakis, F; Kugler, G; Kugler, M; van der Auwera, R	1
Derby, S; Fischberg, D; Kornick, C; Manfredi, PL; Moryl, N; Payne, R; Santiago-Palma, J	1
Brookoff, D; Damask, MC; Dornseif, BE; Doyle, RT; Northfelt, DW; Palangio, M; Portenoy, RK	1
McErlane, KM; Ong, MC; Zheng, M	1
Beaver, WT; Houde, RW; Rogers, A; Wallenstein, SL	1
Chester, MA; Geoghegan, MF; Goodwin, VA; Johnson, NG; Moulin, DE; Murray-Parsons, N	1
Banning, A; Kaiser, F; Sjøgren, P	1
Bailey, SL; Little, WL; Mueller, JB; Parkinson, SK	1
Foley, KM; Houde, RW; Lapin, J; Portenoy, R; Rogers, A; Wallenstein, SL	1
De Angelis, C; Ferris, FD; Hume, S; Kerr, IG; Sone, M	1
Bouquillon, AI; Kreeft, JH; Moulin, DE; Murray-Parsons, N	1
Sawynok, J	1
Foley, KM; Inturrisi, CE; Moulin, DE; Portenoy, RK; Rogers, A	1
Coleman, RR; Lo, SL	1
Brenneis, C; Bruera, E; Chadwick, S; MacDonald, RN; Michaud, M	1
Brenneis, C; Bruera, E; MacDonald, RN	1
Bacovsky, R; Brenneis, C; Bruera, E; Chadwick, S; Emeno, A; MacDonald, N; Michaud, M	1
Brenneis, C; Bruera, E; Hanson, J; MacDonald, RN; MacMillan, K; Michaud, M	1
Adams, F	1
Adams, F; Cruz, L; Deachman, MJ; Zamora, E	1

Reviews

20 review(s) available for hydromorphone and Neoplasms

Article	Year
Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annual review of pharmacology and toxicology, 2000, Volume: 40 Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic	2000
Recurrent Persistent Hiccups on Opioid Treatment: A Case Report and Literature Review. Journal of pain & palliative care pharmacotherapy, 2023, Volume: 37, Issue:1 Topics: Analgesics, Opioid; Codeine; Hiccup; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Pain	2023
Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:1 Topics: Administration, Cutaneous; Analgesics, Opioid; Cachexia; Canada; Female; Fentanyl; Humans; Hydromorphone; Middle Aged; Morphine; Neoplasms; Pain; Palliative Care	2021
Hydromorphone for cancer pain. The Cochrane database of systematic reviews, 2021, 08-05, Volume: 8 Topics: Adult; Analgesics, Opioid; Cancer Pain; Child; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Oxycodone	2021
Opioid Rotation in Cancer Pain Treatment. Deutsches Arzteblatt international, 2018, 03-02, Volume: 115, Issue:9 Topics: Analgesics, Opioid; Buprenorphine; Cancer Pain; Chronic Pain; Fentanyl; Germany; Humans; Hydromorphone; Morphine; Neoplasms; Oxycodone; Pain Management	2018
Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma. Toxicology and applied pharmacology, 2013, Dec-15, Volume: 273, Issue:3 Topics: Animals; Benzazepines; Carcinogenicity Tests; Disease Models, Animal; Humans; Hydromorphone; Lipoma; Mutagenicity Tests; Neoplasms; Phentolamine; Piperidines; Pyrimidines; Pyrroles; Quinoxalines; Rats; Risk Assessment; Varenicline	2013
Treatment of medically refractory cancer pain with a combination of intrathecal neuromodulation and neurosurgical ablation: case series and literature review. Pain medicine (Malden, Mass.), 2014, Volume: 15, Issue:9 Topics: Adolescent; Aged; Bone Neoplasms; Bupivacaine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cordotomy; Female; Humans; Hydromorphone; Infusion Pumps, Implantable; Infusions, Spinal; Intestinal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Pain, Intractable; Palliative Care; Rectal Neoplasms; Retrospective Studies; Spinothalamic Tracts; Thoracic Neoplasms	2014
[New option in the management of cancer pain in Hungary: short acting oral opioid therapy]. Orvosi hetilap, 2015, Jun-21, Volume: 156, Issue:25 Topics: Administration, Oral; Analgesics, Opioid; Analgesics, Short-Acting; Drug Administration Schedule; Drug Approval; Fentanyl; Humans; Hungary; Hydromorphone; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Therapeutic Equivalency; Time Factors	2015
Hydromorphone for cancer pain. The Cochrane database of systematic reviews, 2016, Oct-11, Volume: 10 Topics: Adult; Analgesics, Opioid; Female; Humans; Hydromorphone; Male; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Randomized Controlled Trials as Topic	2016
Equianalgesia: applying evidence-based practice guidelines. Clinical journal of oncology nursing, 2008, Volume: 12, Issue:3 Topics: Analgesia; Analgesics, Opioid; Codeine; Drug Monitoring; Evidence-Based Medicine; Humans; Hydromorphone; Methadone; Morphine; Neoplasms; Nurse's Role; Nursing Assessment; Oncology Nursing; Pain; Practice Guidelines as Topic; Therapeutic Equivalency; Treatment Outcome	2008
The role of hydromorphone in cancer pain treatment: a systematic review. Palliative medicine, 2011, Volume: 25, Issue:5 Topics: Analgesics, Opioid; Humans; Hydromorphone; Neoplasms; Pain; Practice Guidelines as Topic; Randomized Controlled Trials as Topic	2011
Safety and Tolerability of Once-Daily OROS(®) hydromorphone extended-release in opioid-tolerant adults with moderate-to-severe chronic cancer and noncancer pain: pooled analysis of 11 clinical studies. Journal of pain and symptom management, 2012, Volume: 44, Issue:6 Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Chronic Pain; Clinical Trials as Topic; Comorbidity; Evidence-Based Medicine; Female; Humans; Hydromorphone; Incidence; Male; Middle Aged; Neoplasms; Opioid-Related Disorders; Risk Assessment; Risk Factors; Severity of Illness Index; Sex Distribution; United States; Young Adult	2012
Contribution to variability in response to opioids. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:3 Topics: Analgesics, Opioid; Biological Availability; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fentanyl; Humans; Hydromorphone; Male; Maximum Tolerated Dose; Morphine; Neoplasms; Oxycodone; Pain Measurement; Pain, Intractable; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome	2005
Hydromorphone. Journal of pain and symptom management, 2005, Volume: 29, Issue:5 Suppl Topics: Analgesics, Opioid; History, 20th Century; Humans; Hydromorphone; Neoplasms; Pain; Pharmaceutical Preparations; Substance-Related Disorders	2005
Opioid safety: is your patient at risk for respiratory depression? Clinical journal of oncology nursing, 2007, Volume: 11, Issue:2 Topics: Adult; Analgesics, Opioid; Drug Monitoring; Female; Humans; Hydromorphone; Neoplasms; Ovarian Neoplasms; Pain; Respiratory Insufficiency; Risk Factors	2007
Hydromorphone in the management of cancer-related pain: an update on routes of administration and dosage forms. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2007, Volume: 10, Issue:4 Topics: Animals; Disease Management; Dosage Forms; Drug Administration Routes; Humans; Hydromorphone; Neoplasms; Pain; Pain Measurement	2007
Opioid rotation for cancer pain: rationale and clinical aspects. Cancer, 1999, Nov-01, Volume: 86, Issue:9 Topics: Analgesics, Opioid; Fentanyl; Humans; Hydromorphone; Methadone; Morphine; Narcotics; Neoplasms; Pain	1999
Hydromorphone: pharmacology and clinical applications in cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2001, Volume: 9, Issue:2 Topics: Analgesics, Opioid; Drug Administration Routes; Humans; Hydromorphone; Neoplasms; Pain	2001
The therapeutic use of heroin: a review of the pharmacological literature. Canadian journal of physiology and pharmacology, 1986, Volume: 64, Issue:1 Topics: Analgesia; Animals; Brain; Codeine; Depression; Euphoria; Female; Half-Life; Heroin; Humans; Hydromorphone; Kinetics; Liver; Male; Morphine; Morphine Derivatives; Neoplasms; Pain; Sex Factors; Solubility; Terminal Care; Water	1986
Continuous Sc infusion of narcotics for the treatment of cancer pain: an update. Cancer treatment reports, 1987, Volume: 71, Issue:10 Topics: Heroin; Humans; Hydromorphone; Infusion Pumps; Morphine; Narcotics; Neoplasms; Pain	1987

Trials

26 trial(s) available for hydromorphone and Neoplasms

Article	Year
Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II Trial. Journal of the National Comprehensive Cancer Network : JNCCN, 2022, Volume: 20, Issue:9 Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Humans; Hydromorphone; Morphine; Neoplasms; Pain Measurement	2022
Intrathecal delivery of hydromorphone vs morphine for refractory cancer pain: a multicenter, randomized, single-blind, controlled noninferiority trial. Pain, 2020, Volume: 161, Issue:11 Topics: Analgesics, Opioid; Cancer Pain; China; Double-Blind Method; Humans; Hydromorphone; Injections, Spinal; Morphine; Neoplasms; Pain, Postoperative; Single-Blind Method	2020
Comparing Patient-Controlled Analgesia Versus Non-PCA Hydromorphone Titration for Severe Cancer Pain: A Randomized Phase III Trial. Journal of the National Comprehensive Cancer Network : JNCCN, 2021, 08-03, Volume: 19, Issue:10 Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Cancer Pain; Humans; Hydromorphone; Neoplasms; Pain	2021
A double-blind, randomized comparative study to investigate the morphine to hydromorphone conversion ratio in Japanese cancer patients. Japanese journal of clinical oncology, 2018, May-01, Volume: 48, Issue:5 Topics: Aged; Analgesics, Opioid; Double-Blind Method; Female; Humans; Hydromorphone; Japan; Male; Morphine; Neoplasms; Pain Management	2018
A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients. Japanese journal of clinical oncology, 2018, Jun-01, Volume: 48, Issue:6 Topics: Aged; Analgesics, Opioid; Asian People; Cancer Pain; Delayed-Action Preparations; Demography; Depression; Double-Blind Method; Female; Humans; Hydromorphone; Japan; Male; Neoplasms; Oxycodone; Pain Measurement; Powders; Tablets; Treatment Outcome	2018
A prospective, open-label, multicenter study of the clinical efficacy of extended-release hydromorphone in treating cancer pain inadequately controlled by other analgesics. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Breakthrough Pain; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain Measurement; Prospective Studies; Sleep; Treatment Outcome; Young Adult	2014
Safety and efficacy of once-daily hydromorphone extended-release versus twice-daily oxycodone hydrochloride controlled-release in chinese patients with cancer pain: a phase 3, randomized, double-blind, multicenter study. The journal of pain, 2014, Volume: 15, Issue:8 Topics: Adolescent; Adult; Aged; Analgesics, Opioid; China; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Pain Measurement; Sample Size; Treatment Outcome; Young Adult	2014
Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine. European journal of pain (London, England), 2009, Volume: 13, Issue:7 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Buprenorphine; Cohort Studies; Constipation; Delayed-Action Preparations; Female; Fentanyl; Gastrointestinal Diseases; Humans; Hydromorphone; Laxatives; Male; Middle Aged; Nausea; Neoplasms; Pain, Intractable; Prospective Studies; Vomiting	2009
Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Aug-15, Volume: 22, Issue:16 Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Humans; Hydromorphone; Middle Aged; Morphine; Neoplasms; Pain; Placebos; Quality of Life	2004
Comparative efficacy of oral extended-release hydromorphone and immediate-release hydromorphone in patients with persistent moderate to severe pain: two randomized controlled trials. Journal of pain and symptom management, 2005, Volume: 29, Issue:6 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Terminal Care	2005
[Controlled-release hydromorphone in elderly patients with severe pain of different etiologies. Results of an observational study]. MMW Fortschritte der Medizin, 2005, Oct-06, Volume: 147 Suppl 3 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Pain Measurement; Treatment Outcome	2005
Effect of hydromorphone on ventilation in palliative care patients with dyspnea. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2008, Volume: 16, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Blood Gas Monitoring, Transcutaneous; Carbon Dioxide; Dyspnea; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Oxygen; Palliative Care; Prospective Studies; Pulse; Respiratory Function Tests; Respiratory Mechanics; Severity of Illness Index	2008
Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2008, Volume: 16, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Constipation; Female; Humans; Hydromorphone; Male; Middle Aged; Morphine; Nausea; Neoplasms; Pain; Pain Measurement; Prospective Studies; Risk Factors; Vomiting	2008
A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain. Journal of palliative medicine, 2008, Volume: 11, Issue:4 Topics: Administration, Cutaneous; Adult; Aged; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Female; Health Status Indicators; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement	2008
Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain. Cancer, 1994, Sep-15, Volume: 74, Issue:6 Topics: Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Pain Measurement	1994
Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone. Journal of clinical pharmacology, 1995, Volume: 35, Issue:1 Topics: Administration, Oral; Biological Availability; Delayed-Action Preparations; Double-Blind Method; Female; Glucuronates; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain Management; Retrospective Studies	1995
Comparison of hydromorphone continuous subcutaneous infusion and basal rate subcutaneous infusion plus PCA in cancer pain: a pilot study. Pain, 1993, Volume: 53, Issue:1 Topics: Adult; Analgesia, Patient-Controlled; Double-Blind Method; Female; Humans; Hydromorphone; Hypnotics and Sedatives; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Pain Measurement; Pain, Intractable; Pilot Projects; Respiration	1993
Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Pain, 1995, Volume: 62, Issue:2 Topics: Aged; Analgesics, Opioid; Capsules; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Male; Methadone; Middle Aged; Neoplasms; Pain; Prospective Studies; Suppositories	1995
A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:5 Topics: Adult; Aged; Canada; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Pain Measurement; Palliative Care	1996
Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain. Cancer, 1997, Apr-01, Volume: 79, Issue:7 Topics: Analgesics, Opioid; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Oxycodone; Pain	1997
Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain. Pain, 2002, Volume: 96, Issue:3 Topics: Adult; Aged; Analgesics, Opioid; Female; Fentanyl; Humans; Hydromorphone; Levorphanol; Male; Methadone; Middle Aged; Morphine; Neoplasms; Pain; Patient Satisfaction; Prospective Studies	2002
Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain. Journal of pain and symptom management, 2002, Volume: 23, Issue:5 Topics: Adult; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Delivery Systems; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Titrimetry	2002
Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer. Journal of clinical pharmacology, 1977, Volume: 17, Issue:4 Topics: Administration, Oral; Adult; Aged; Analgesics; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Hydromorphone; Injections, Intramuscular; Male; Middle Aged; Morphine; Neoplasms; Oxymorphone; Pain; Placebos; Time Factors	1977
Clinical analgesic assay of repeated and single doses of heroin and hydromorphone. Pain, 1990, Volume: 41, Issue:1 Topics: Affect; Analgesics; Female; Heroin; Humans; Hydromorphone; Hypnotics and Sedatives; Male; Neoplasms; Pain Measurement; Pain, Postoperative; Time Factors	1990
Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. Lancet (London, England), 1991, Feb-23, Volume: 337, Issue:8739 Topics: Aged; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Hydromorphone; Infusion Pumps, Implantable; Infusions, Intravenous; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Pain; Palliative Care; Severity of Illness Index; Time Factors	1991
Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain. Journal of the National Cancer Institute, 1988, Sep-21, Volume: 80, Issue:14 Topics: Female; Humans; Hydromorphone; Injections, Subcutaneous; Male; Neoplasms; Pain, Intractable; Self Administration	1988

Other Studies

42 other study(ies) available for hydromorphone and Neoplasms

Article	Year
Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Hydromorphone; Japan; Male; Methadone; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Pain Measurement; Retrospective Studies; Tapentadol	2021
Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study. Journal of pain and symptom management, 2023, Volume: 66, Issue:2 Topics: Aged; Analgesics, Opioid; Cohort Studies; Dyspnea; Humans; Hydromorphone; Morphine; Neoplasms; Oxycodone	2023
[Drug therapy for cancer-related pain-evidence regarding hydromorphone, oxycodone, and methadone : Presentation and summary of three Cochrane reviews]. Urologie (Heidelberg, Germany), 2023, Volume: 62, Issue:6 Topics: Analgesics, Opioid; Cancer Pain; Humans; Hydromorphone; Methadone; Neoplasms; Oxycodone	2023
[Hydromorphone in Cancer Patients-A Retrospective Study]. Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:12 Topics: Analgesics, Opioid; Humans; Hydromorphone; Neoplasms; Oxycodone; Retrospective Studies	2020
Intrathecal patient-controlled analgesia has nothing to do with breakthrough cancer pain. Pain, 2021, 05-01, Volume: 162, Issue:5 Topics: Analgesia, Epidural; Analgesia, Patient-Controlled; Breakthrough Pain; Cancer Pain; Humans; Hydromorphone; Morphine; Neoplasms; Single-Blind Method	2021
Hydromorphone Conversion Dilemma: A Millennial Problem. Journal of pain and symptom management, 2018, Volume: 56, Issue:3 Topics: Administration, Intravenous; Analgesics, Opioid; Humans; Hydromorphone; Neoplasms; Pain	2018
Circulating miRNA Signature as a Potential Biomarker for the Prediction of Analgesic Efficacy of Hydromorphone. International journal of molecular sciences, 2019, Apr-03, Volume: 20, Issue:7 Topics: Aged; Analgesics; Biomarkers; Circulating MicroRNA; Female; Gene Expression Profiling; Humans; Hydromorphone; Male; Morphine; Neoplasms; Receptors, Opioid, mu; Treatment Outcome	2019
Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy. Anesthesia and analgesia, 2020, Volume: 130, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Constipation; Female; Humans; Hydromorphone; Injections, Spinal; Male; Middle Aged; Neoplasms; Pain Measurement; Pain, Postoperative; Prospective Studies; Treatment Outcome; Young Adult	2020
Practices and perceptions regarding intravenous opioid infusion and cancer pain management. Cancer, 2019, 11-01, Volume: 125, Issue:21 Topics: Adult; Analgesics, Opioid; Cancer Pain; Clinical Competence; Cross-Sectional Studies; Female; Fentanyl; Humans; Hydromorphone; Infusions, Intravenous; Male; Middle Aged; Morphine; Neoplasms; Nurses; Pain Management; Surveys and Questionnaires; Time Factors	2019
What is your gut feeling about opioid rotation? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Jan-20, Volume: 33, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Biological Availability; Delayed-Action Preparations; Drug Administration Schedule; Fentanyl; Humans; Hydromorphone; Intestinal Obstruction; Male; Methadone; Middle Aged; Morphine; Neoplasms; Pain; Pain Management; Quality of Life	2015
When Hydromorphone Is Not Working, Try Loratadine: An Emergency Department Case of Loratadine as Abortive Therapy for Severe Pegfilgrastim-Induced Bone Pain. The Journal of emergency medicine, 2017, Volume: 52, Issue:2 Topics: Antineoplastic Agents; Bone and Bones; Emergency Service, Hospital; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Hydromorphone; Loratadine; Middle Aged; Neoplasms; Neutropenia; Pain Management; Pain, Intractable; Polyethylene Glycols; Recombinant Proteins	2017
Clinical efficacy of OROS® hydromorphone in patients suffering from severe chronic pain: A Study undertaken in routine clinical practice. Wiener klinische Wochenschrift, 2011, Volume: 123, Issue:17-18 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain Measurement; Quality of Life; Slovenia; Treatment Outcome	2011
Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:8 Topics: Analgesics, Opioid; Female; Humans; Hydromorphone; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Pain Management; Pain Measurement; Pain, Intractable; Retrospective Studies; Treatment Failure; Treatment Outcome	2012
[Pain therapy in patients with tumors. According to graduated schedule and hourly plan]. MMW Fortschritte der Medizin, 2003, Oct-02, Volume: 145, Issue:40 Topics: Analgesics, Opioid; Humans; Hydromorphone; Neoplasms; Pain; Time Factors	2003
Epidural treatment in advanced cancer patients. Anesthesia and analgesia, 2004, Volume: 98, Issue:5 Topics: Analgesia, Epidural; Analgesics, Opioid; Humans; Hydromorphone; Injections, Spinal; Neoplasms; Pain, Intractable; Palliative Care	2004
[Pain reduced and quality of life improved by sustained-release hydromorphone. Results of an observational study]. MMW Fortschritte der Medizin, 2004, Dec-09, Volume: 146, Issue:Suppl 3-4 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Pain Measurement; Patient Compliance; Quality of Life; Time Factors	2004
Rotation to methadone after opioid dose escalation: How should individualization of dosing occur? Journal of pain & palliative care pharmacotherapy, 2005, Volume: 19, Issue:2 Topics: Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Methadone; Middle Aged; Neoplasms; Neurotoxicity Syndromes; Pain, Intractable; Palliative Care	2005
Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain. Clinical therapeutics, 2006, Volume: 28, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Pain Measurement; Prospective Studies; Severity of Illness Index; Treatment Outcome	2006
[Delayed action and rapidly effective in combination. Hydromorphone--already a WHO stage 3 drug]. MMW Fortschritte der Medizin, 2006, May-11, Volume: 148, Issue:19 Topics: Analgesics, Opioid; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Humans; Hydromorphone; Neoplasms; Pain	2006
Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study. Japanese journal of clinical oncology, 2007, Volume: 37, Issue:4 Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Female; Fentanyl; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Pain; Pain Measurement; Palliative Care; Patient Satisfaction; Retrospective Studies; Statistics, Nonparametric	2007
[Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration]. Deutsche medizinische Wochenschrift (1946), 2007, Volume: 132, Issue:38 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Dyspnea; Female; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Oxygen Inhalation Therapy; Palliative Care; Prospective Studies; Respiration; Severity of Illness Index	2007
Opioid hyperexcitability: the application of alternate opioid therapy. Pain, 1993, Volume: 53, Issue:3 Topics: Adult; Aged; Drug Tolerance; Female; Humans; Hydromorphone; Male; Morphine; Myoclonus; Narcotics; Neoplasms; Pain	1993
Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer, 1996, Aug-15, Volume: 78, Issue:4 Topics: Administration, Oral; Aged; Aged, 80 and over; Analgesics, Opioid; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydromorphone; Injections, Subcutaneous; Male; Methadone; Middle Aged; Morphine; Neoplasms; Pain; Retrospective Studies	1996
Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study. Pain, 1997, Volume: 72, Issue:1-2 Topics: Aged; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Pain; Pain Measurement; Palliative Care; Retrospective Studies	1997
Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences. Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aged; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Linear Models; Male; Methadone; Middle Aged; Neoplasms; Pain; Receptors, Opioid; Retrospective Studies	1998
Comment on Manfredi et al.,Pain, 70 (1997) 199-101. Pain, 1998, Volume: 77, Issue:1 Topics: Analgesics, Opioid; Humans; Hydromorphone; Injections, Intravenous; Methadone; Morphine; Neoplasms; Palliative Care; Retreatment	1998
Opioid conversion guidelines for managing adult cancer pain. The American journal of nursing, 1999, Volume: 99, Issue:10 Topics: Administration, Oral; Analgesics, Opioid; Chronic Disease; Female; Humans; Hydromorphone; Infusions, Intravenous; Mathematics; Middle Aged; Morphine; Neoplasms; Pain; Pain Measurement; Salvage Therapy; Therapeutic Equivalency; Titrimetry	1999
Hydromorphone. The American journal of nursing, 2001, Volume: 101, Issue:2 Topics: Analgesics, Opioid; Chronic Disease; Humans; Hydromorphone; Meperidine; Morphine; Neoplasms; Pain	2001
Morphine and alternative opioids in cancer pain: the EAPC recommendations. British journal of cancer, 2001, Mar-02, Volume: 84, Issue:5 Topics: Administration, Oral; Analgesics, Opioid; Chemistry, Pharmaceutical; Drug Administration Schedule; Fentanyl; Humans; Hydromorphone; Infusions, Intravenous; Injections, Spinal; Injections, Subcutaneous; Methadone; Morphine; Neoplasms; Oxycodone; Pain; Palliative Care	2001
[New Level III opioids of the World Health Organization]. La Revue de medecine interne, 2002, Volume: 23, Issue:1 Topics: Administration, Oral; Analgesics, Opioid; Clinical Trials as Topic; Delayed-Action Preparations; Fentanyl; Humans; Hydromorphone; Morphine; Neoplasms; Pain; World Health Organization	2002
[Opioid rotation in pain therapy. Case report]. Der Anaesthesist, 2002, Volume: 51, Issue:1 Topics: Administration, Cutaneous; Chronic Disease; Fentanyl; Humans; Hydromorphone; Injections, Subcutaneous; Male; Middle Aged; Morphine; Neoplasms; Pain	2002
Hydromorphone metabolites: isolation and identification from pooled urine samples of a cancer patient. Xenobiotica; the fate of foreign compounds in biological systems, 2002, Volume: 32, Issue:5 Topics: Analgesics, Opioid; Chromatography, High Pressure Liquid; Dihydromorphine; Female; Glucuronates; Glucuronides; Humans; Hydromorphone; Mass Spectrometry; Molecular Structure; Neoplasms	2002
Subcutaneous narcotic infusions for cancer pain: treatment outcome and guidelines for use. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1992, Mar-15, Volume: 146, Issue:6 Topics: Costs and Cost Analysis; Female; Humans; Hydromorphone; Infusion Pumps; Male; Middle Aged; Morphine; Neoplasms; Pain, Intractable; Palliative Care; Patient Satisfaction; Retrospective Studies	1992
Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids. Acta anaesthesiologica Scandinavica, 1992, Volume: 36, Issue:5 Topics: Acetaminophen; Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Hydromorphone; Male; Meperidine; Middle Aged; Morphine; Morphine Derivatives; Neoplasms; Nicotinic Acids; Pain	1992
Myoclonic seizure activity with chronic high-dose spinal opioid administration. Anesthesiology, 1990, Volume: 72, Issue:4 Topics: Drug Administration Schedule; Epilepsies, Myoclonic; Female; Humans; Hydromorphone; Injections, Spinal; Male; Middle Aged; Morphine; Neoplasms; Pain, Intractable; Time Factors	1990
Inpatient narcotic infusions for patients with cancer pain. Journal of palliative care, 1990,Summer, Volume: 6, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Hydromorphone; Infusions, Parenteral; Male; Middle Aged; Morphine; Neoplasms; Pain, Intractable; Palliative Care; Retrospective Studies	1990
I.v. infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer treatment reports, 1986, Volume: 70, Issue:5 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Humans; Hydromorphone; Infant; Infusions, Parenteral; Levorphanol; Methadone; Middle Aged; Morphine; Narcotics; Neoplasms; Oxymorphone; Pain, Intractable; Palliative Care; Retrospective Studies	1986
Exceptionally high narcotic analgesic requirements in a terminally ill cancer patient. Clinical pharmacy, 1986, Volume: 5, Issue:10 Topics: Adult; Analgesics, Opioid; Combined Modality Therapy; Drug Tolerance; Female; Humans; Hydromorphone; Methadone; Morphine; Neoplasms; Pain	1986
Continuous sc infusion of narcotics using a portable disposable device in patients with advanced cancer. Cancer treatment reports, 1987, Volume: 71, Issue:6 Topics: Ambulatory Care; Female; Humans; Hydromorphone; Infusion Pumps; Male; Middle Aged; Morphine; Narcotics; Neoplasms; Pain	1987
Use of the subcutaneous route for the administration of narcotics in patients with cancer pain. Cancer, 1988, Jul-15, Volume: 62, Issue:2 Topics: Cost-Benefit Analysis; Female; Home Care Services; Humans; Hydromorphone; Infusion Pumps; Infusions, Parenteral; Male; Middle Aged; Morphine; Neoplasms; Pain, Intractable	1988
Emergency intravenous sedation of the delirious, medically ill patient. The Journal of clinical psychiatry, 1988, Volume: 49 Suppl Topics: Critical Care; Delirium; Drug Therapy, Combination; Haloperidol; Humans; Hydromorphone; Infusions, Intravenous; Injections, Intravenous; Lorazepam; Multiple Organ Failure; Neoplasms; Pain, Intractable; Palliative Care	1988
Focal subdermal toxicity with subcutaneous opioid infusion in patients with cancer pain. Journal of pain and symptom management, 1989, Volume: 4, Issue:1 Topics: Adult; Aged; Erythema; Female; Humans; Hydromorphone; Infusions, Parenteral; Male; Middle Aged; Necrosis; Neoplasms; Pain; Skin	1989